|
POGK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.692400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.385810E-01 |
| Normal-vs-Stage2 |
1.856570E-01 |
| Normal-vs-Stage3 |
2.497000E-01 |
| Normal-vs-Stage4 |
5.538400E-01 |
| Stage1-vs-Stage2 |
7.140600E-01 |
| Stage1-vs-Stage3 |
8.101900E-02 |
| Stage1-vs-Stage4 |
1.762430E-01 |
| Stage2-vs-Stage3 |
7.143900E-02 |
| Stage2-vs-Stage4 |
2.806000E-01 |
| Stage3-vs-Stage4 |
9.310200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.755400E-01 |
| Normal-vs-AfricanAmerican |
9.316600E-01 |
| Normal-vs-Asian |
2.406000E-01 |
| Caucasian-vs-AfricanAmerican |
8.408200E-01 |
| Caucasian-vs-Asian |
6.984600E-01 |
| AfricanAmerican-vs-Asian |
6.162600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.730990E-01 |
| Normal-vs-Female |
5.910000E-02 |
| Male-vs-Female |
7.355400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.796400E-01 |
| Normal-vs-Extreme_Weight |
5.958100E-02 |
| Normal-vs-Obese |
5.770800E-01 |
| Normal-vs-Extreme_Obese |
5.610600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.019400E-01 |
| Normal_Weight-vs-Obese |
3.881000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.144200E-01 |
| Extreme_Weight-vs-Obese |
5.509900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.142400E-01 |
| Obese-vs-Extreme_Obese |
4.744400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.009990E-01 |
| Normal-vs-Age(41-60Yrs) |
4.615000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.086830E-01 |
| Normal-vs-Age(81-100Yrs) |
5.783500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.374780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.122090E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.274430E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.784300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.302200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.648800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.746200E-01 |
| Normal-VS-Type2 PRCC |
1.489640E-01 |
| Normal-VS-KIRP CIMP |
9.806100E-02 |
| Normal-VS-Unclassified PRCC |
8.508200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.796400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.081800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.743400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.538700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.609800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.710400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.204530E-03 |
| Normal-vs-N1 |
1.151800E-02 |
| Normal-vs-N2 |
5.790600E-01 |
| N0-vs-N1 |
8.427500E-04 |
| N0-vs-N2 |
1.358630E-01 |
| N1-vs-N2 |
3.404800E-01 |
|
|
